Showing 4991-5000 of 5646 results for "".
- Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19https://modernod.com/news/johnson-johnson-announces-a-lead-vaccine-candidate-for-covid-19/2477489/Johnson & Johnson announced a $1 billion deal with the U.S. government to create enough manufacturing capacity to make more than 1 billion doses of a potential vaccine for COVID-19. Johnson & Johnson said on Monday it has been working on a vaccine since January 2020 and expects to initiat
- The Allergan Foundation Donates $2 Million to Community Organizations on Front Line of COVID-19 Responsehttps://modernod.com/news/the-allergan-foundation-donates-2-million-to-community-organizations-on-front-line-of-covid-19-response/2477485/Allergan announced that The Allergan Foundation has awarded approximately $13 million in charitable grants in 2020. The 2020 donations support programs dedicated to the COVID-19 pandemic response, as well as initiatives supporting mental health, eye care, and breast
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- Eyewire News Exclusive: Q&A With Anne Coleman, MD, PhD, President of AAOhttps://modernod.com/news/eyewire-news-exclusive-qa-with-anne-coleman-md-phd-president-of-aao/2477474/The American Academy of Ophthalmology (AAO) continues to update its guidance for ophthalmologists dealing with the COVID-19 pandemic. Most recently, AAO updated its guidance on vaccine and t
- NYU Med School Will Graduate Students Early to Help New York Fight Coronavirushttps://modernod.com/news/nyu-med-school-will-graduate-students-early-to-help-new-york-fight-coronavirus/2477471/As COVID-19 continues to slam New York City hospitals, New York University’s Grossman School of Medicine this week took the dramatic step of letting its graduating class depart early to join the response effort, according to a TIME
- European Glaucoma Society Postpones Annual Congresshttps://modernod.com/news/european-glaucoma-society-postpones-annual-congress/2477472/The Executive Committee of the European Glaucoma Society has decided to postpone the 14th EGS Congress in Brussels, Belgium to December due to the global COVID-10 pandemic. A statement posted on the EGS website read: “In these times of uncertainty, the first
- UK Commits £210 Million Toward Global Efforts to Find COVID-19 Vaccinehttps://modernod.com/news/uk-commits-210-million-toward-global-efforts-to-find-covid-19-vaccine/2477469/The UK government said it would contribute £210 million ($255 million) toward international efforts aimed at finding a vaccine against the novel coronavirus, according to a FirstWord report. The funding will be channelled to the Coalition for Epidemic Preparedness Innovations (CEPI), which
- Prevent Blindness Releases Message to Eye Care Patients Regarding the COVID-19 Pandemichttps://modernod.com/news/prevent-blindness-releases-message-to-eye-care-patients-regarding-the-covid-19-pandemic/2477470/In response to the numerous queries from patients and caregivers, Prevent Blindness has issued the following statement in regards to eye care during the coronavirus pandemic. “For everyone’s health and s
- Aldeyra to Screen Clinical-Stage Compounds for Activity in COVID-19 Infectionhttps://modernod.com/news/aldeyra-to-screen-clinical-stage-compounds-for-activity-in-covid-19-infection/2477461/Aldeyra Therapeutics announced that it will begin screening its library of novel reactive aldehyde species (RASP) inhibitors, including ADX-629 and reproxalap, for potential anti-inflammatory and antiviral activity in the treatment of COVID-19 infection. ADX-629 and reproxalap are structur
- MicroSurgical Technology (MST) Announces the Acquisition of IP and Assets of IRISS Medical Technologies Limitedhttps://modernod.com/news/microsurgical-technology-mst-announces-the-acquisition-of-ip-and-assets-of-iriss-medical-technologies-limited/2477460/MicroSurgical Technology (MST) has acquired the IP and assets of IRISS Medical Technologies Limited, a United Kingdom private limited company, related to the Volk Eye Check product and additional technology and intellectual property. Terms of the deal were not disclosed. The Volk E